Somatostatin and growth hormone regulation in cancer

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Somatostatin analogues are used clinically in a variety of pituitary and gastroenteropancreatic tumours. In addition, they may influence breast and prostate growth either directly through somatostatin receptors or indirectly through inhibition of growth hormone and prolactin release. Somatostatin analogues may interfere with EGF/TGF α-stimulated growth of these tumours and can suppress circulating levels of IGF-I in addition.

Original languageEnglish (US)
Pages (from-to)31-36
Number of pages6
JournalBiotherapy
Volume4
Issue number1
DOIs
StatePublished - Jan 1 1992

Fingerprint

Somatostatin
Growth Hormone
Somatostatin Receptors
Pituitary Neoplasms
Growth
Insulin-Like Growth Factor I
Epidermal Growth Factor
Prolactin
Prostate
Neoplasms
Breast

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

@article{2b6cc90655b44419846a0f0f4b75cace,
title = "Somatostatin and growth hormone regulation in cancer",
abstract = "Somatostatin analogues are used clinically in a variety of pituitary and gastroenteropancreatic tumours. In addition, they may influence breast and prostate growth either directly through somatostatin receptors or indirectly through inhibition of growth hormone and prolactin release. Somatostatin analogues may interfere with EGF/TGF α-stimulated growth of these tumours and can suppress circulating levels of IGF-I in addition.",
author = "Andrea Manni",
year = "1992",
month = "1",
day = "1",
doi = "10.1007/BF02171707",
language = "English (US)",
volume = "4",
pages = "31--36",
journal = "Biotherapy",
issn = "0914-2223",
publisher = "Japanese Society for Cancer Chemotherapy",
number = "1",

}

Somatostatin and growth hormone regulation in cancer. / Manni, Andrea.

In: Biotherapy, Vol. 4, No. 1, 01.01.1992, p. 31-36.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Somatostatin and growth hormone regulation in cancer

AU - Manni, Andrea

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Somatostatin analogues are used clinically in a variety of pituitary and gastroenteropancreatic tumours. In addition, they may influence breast and prostate growth either directly through somatostatin receptors or indirectly through inhibition of growth hormone and prolactin release. Somatostatin analogues may interfere with EGF/TGF α-stimulated growth of these tumours and can suppress circulating levels of IGF-I in addition.

AB - Somatostatin analogues are used clinically in a variety of pituitary and gastroenteropancreatic tumours. In addition, they may influence breast and prostate growth either directly through somatostatin receptors or indirectly through inhibition of growth hormone and prolactin release. Somatostatin analogues may interfere with EGF/TGF α-stimulated growth of these tumours and can suppress circulating levels of IGF-I in addition.

UR - http://www.scopus.com/inward/record.url?scp=0026500158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026500158&partnerID=8YFLogxK

U2 - 10.1007/BF02171707

DO - 10.1007/BF02171707

M3 - Article

VL - 4

SP - 31

EP - 36

JO - Biotherapy

JF - Biotherapy

SN - 0914-2223

IS - 1

ER -